B. Riley Wealth Advisors
VVOS icon

B. Riley Wealth Advisors’s Vivos Therapeutics VVOS Stock Holding History

B. Riley Wealth Advisors’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.19K Sell
35,066
-3,000
-8% -$902 ﹤0.01% 1088
2026
Q2 		$18.8K Hold
38,066
– – ﹤0.01% 899
2026
Q1 		$41.5K Sell
38,066
-5,465
-13% -$8.76K ﹤0.01% 838
2025
Q4 		$88.4K Hold
43,531
– – ﹤0.01% 942
2025
Q3 		$135K Sell
43,531
-26,000
-37% -$118K 0.01% 936
2025
Q2 		$220K Hold
69,531
– – 0.01% 849
2025
Q1 		$198K Buy
+69,531
New +$273K 0.01% 1156
2022
Q3 		– Sell
-4,032
Closed -$131K – 1537
2022
Q2 		$131K Buy
4,032
+89
+2% +$3.7K 0.01% 1099
2022
Q1 		$265K Buy
3,943
+772
+24% +$50.5K 0.01% 1071
2021
Q4 		$179K Buy
3,171
+1,132
+56% +$91.1K 0.01% 1289
2021
Q3 		$206K Buy
2,039
+650
+47% +$68.3K 0.01% 1236
2021
Q2 		$172K Buy
1,389
+250
+22% +$40.7K 0.01% 1246
2021
Q1 		$190K Buy
+1,139
New +$203K 0.01% 1207

Other funds holding VVOS

Centurion Wealth Management
Centurion Wealth Management Mclean, Virginia $415M AUM 17.23% 1-Year Est. Return
Acorn Wealth Advisors
Acorn Wealth Advisors Grand Blanc, Michigan $407M AUM 14.44% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
LA
Latitude Advisors Vero Beach, Florida $323M AUM 17.08% 1-Year Est. Return
Kozak & Associates
Kozak & Associates Highlands Ranch, Colorado $553M AUM 17.51% 1-Year Est. Return

B. Riley Wealth Advisors's VVOS Position: Q3 2026 in Review

B. Riley Wealth Advisors reduced its Vivos Therapeutics (VVOS) stake by 7.9% in Q3 2026, selling an estimated $902 and leaving 35,066 shares worth $5.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

B. Riley Wealth Advisors first reported a position in VVOS in Q1 2021 and has held it in 13 quarters since. The position peaked at $265K in Q1 2022. 8 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.

  • B. Riley Wealth Advisors held 35,066 shares of Vivos Therapeutics worth $5.19K as of Q3 2026.
  • B. Riley Wealth Advisors sold 3,000 Vivos Therapeutics shares in Q3 2026, an estimated $902.
  • Vivos Therapeutics made up ﹤0.01% of B. Riley Wealth Advisors's portfolio in Q3 2026, its #1088 holding.
  • B. Riley Wealth Advisors first reported a position in Vivos Therapeutics in Q1 2021 and has held it in 13 quarters since.
  • B. Riley Wealth Advisors's Vivos Therapeutics position peaked at $265K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.